DongKoo Bio & Pharma Co., Ltd.

KOSDAQ:A006620 Stok Raporu

Piyasa değeri: ₩142.5b

DongKoo Bio & Pharma Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 4/6

DongKoo Bio & Pharma has been growing earnings at an average annual rate of 11.7%, while the Pharmaceuticals industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 16.2% per year. DongKoo Bio & Pharma's return on equity is 11.5%, and it has net margins of 5.4%.

Anahtar bilgiler

11.7%

Kazanç büyüme oranı

12.7%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi11.3%
Gelir büyüme oranı16.2%
Özkaynak getirisi11.5%
Net Marj5.4%
Son Kazanç Güncellemesi30 Jun 2024

Yakın geçmiş performans güncellemeleri

We Think That There Are Issues Underlying DongKoo Bio & Pharma's (KOSDAQ:006620) Earnings

Mar 27
We Think That There Are Issues Underlying DongKoo Bio & Pharma's (KOSDAQ:006620) Earnings

Recent updates

More Unpleasant Surprises Could Be In Store For DongKoo Bio & Pharma Co., Ltd.'s (KOSDAQ:006620) Shares After Tumbling 32%

Aug 23
More Unpleasant Surprises Could Be In Store For DongKoo Bio & Pharma Co., Ltd.'s (KOSDAQ:006620) Shares After Tumbling 32%

Should You Be Adding DongKoo Bio & Pharma (KOSDAQ:006620) To Your Watchlist Today?

Jul 25
Should You Be Adding DongKoo Bio & Pharma (KOSDAQ:006620) To Your Watchlist Today?

We Think That There Are Issues Underlying DongKoo Bio & Pharma's (KOSDAQ:006620) Earnings

Mar 27
We Think That There Are Issues Underlying DongKoo Bio & Pharma's (KOSDAQ:006620) Earnings

Gelir ve Gider Dağılımı

DongKoo Bio & Pharma nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

KOSDAQ:A006620 Gelir, gider ve kazançlar (KRW Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 24240,39513,005120,69610,378
31 Mar 24231,40914,307114,07510,449
31 Dec 23215,68611,812105,62110,752
30 Sep 23201,7156,822100,5669,220
30 Jun 23199,5078,68597,7858,361
31 Mar 23196,1746,25194,3808,326
31 Dec 22194,9886,61491,6388,258
30 Sep 22187,1098,40187,1578,263
30 Jun 22176,8587,64181,8029,131
31 Mar 22166,04511,36577,5119,702
31 Dec 21155,1499,32773,09310,114
30 Sep 21149,0317,45570,36810,698
30 Jun 21144,0817,34967,42611,526
31 Dec 20139,2169,14061,38610,751
31 Dec 17101,12410,94343,3233,681
30 Sep 17100,46815,87741,5272,989
30 Jun 1795,94213,61840,3642,727
31 Dec 1687,36310,91339,3832,111
31 Dec 1580,3694,03038,4102,819

Kaliteli Kazançlar: A006620 has a high level of non-cash earnings.

Büyüyen Kar Marjı: A006620's current net profit margins (5.4%) are higher than last year (4.4%).


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: A006620's earnings have grown by 11.7% per year over the past 5 years.

Büyüme Hızlandırma: A006620's earnings growth over the past year (49.7%) exceeds its 5-year average (11.7% per year).

Kazançlar vs. Sektör: A006620 earnings growth over the past year (49.7%) exceeded the Pharmaceuticals industry 21.9%.


Özkaynak Getirisi

Yüksek ROE: A006620's Return on Equity (11.5%) is considered low.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin